首页> BMC cancer> High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy.

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy.

导出 OA

翻译打印收藏纠错

第一作者： Michaela,Ramser

第一单位： Department of Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

作者： Michaela,Ramser ^[1] ; Simone,Eichelberger ^[1] ; Silvio,Däster ^[1] ; Benjamin,Weixler ^[1] ; Marko,Kraljević ^[2] ; Robert,Mechera ^[1] ; Athanasios,Tampakis ^[1] ; Tarik,Delko ^[1] ; Uwe,Güth ^[3] ; Sylvia,Stadlmann ^[4] ; Luigi,Terracciano ^[5] ; Raoul A,Droeser ^[6] ; Gad,Singer ^[4]

作者单位： Department of Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. ^[1] Spital Limmattal, Urdorferstrasse 100, 8952, Schlieren, Switzerland. ^[2] Brustzentrum Zürich, Seefeldstrasse 214, 8008, Zürich, Switzerland.;Department of Gynecology and Obstetrics, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. ^[3] Institute of Pathology, Kantonsspital Baden AG, Im Ergel 1, 5404, Baden, Switzerland.;Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, 4031, Basel, Switzerland. ^[4] Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, 4031, Basel, Switzerland. ^[5] Department of Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. raoul.droeser@usb.ch. ^[6]

关键词 CD134 Chemosensitivity OX40 Ovarian cancer